D. Villaluna

发表

Prospective Evaluation of Galactomannan and (1→3) β-d-Glucan Assays as Diagnostic Tools for Invasive Fungal Disease in Children, Adolescents, and Young Adults With Acute Myeloid Leukemia Receiving Fungal Prophylaxis.

T. Westling, J. Wingard, S. Alexander, 2021, Journal of the Pediatric Infectious Diseases Society.

Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: A report from the Children's Oncology Group

Helen X. Chen, P. Adamson, J. Reid, 2014, Pediatric blood & cancer.

Role of age and health in treatment recommendations for older adults with breast cancer: the perspective of oncologists and primary care providers.

A. Naeim, S. Bhatia, J. Mortimer, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sodium thiosulfate for prevention of cisplatin-induced hearing loss: updated survival from ACCL0431.

M. Krailo, E. Orgel, L. Sung, 2022, The Lancet. Oncology.

EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment†

K. S. Hall, L. Trani, M. Sydes, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Eﬀ ects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial

B. Pollock, K. Knight, E. Neuwelt, 2016 .

Chlorhexidine gluconate bathing in children with cancer or those undergoing hematopoietic stem cell transplantation: A double‐blinded randomized controlled trial from the Children's Oncology Group

A. Addetia, A. Milstone, A. Adler, 2020, Cancer.

In reply [2]

L. Constine, D. Friedman, R. Sposto, 2007 .

Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial.

B. Pollock, K. Knight, E. Neuwelt, 2017, The Lancet. Oncology.

Effect of Caspofungin vs Fluconazole Prophylaxis on Invasive Fungal Disease Among Children and Young Adults With Acute Myeloid Leukemia: A Randomized Clinical Trial.

J. Wingard, S. Alexander, C. Callahan, 2019, JAMA.

Prospective Evaluation of the Fungitell® (1→3) Beta‐D‐Glucan Assay as a Diagnostic Tool for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplantation: A Report from the Children's Oncology Group

S. Alexander, W. Steinbach, T. Zaoutis, 2022, Pediatric transplantation.

Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group

C. Shields, J. O'Brien, B. Langholz, 2017, Pediatric blood & cancer.

α‐Fetoprotein as a predictor of outcome for children with germ cell tumors: A report from the Malignant Germ Cell International Consortium

C. Rodríguez-Galindo, A. L. Frazier, J. Amatruda, 2019, Cancer.

Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group.

N. Heerema, W. Woods, H. Sather, 2006, Blood.

A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group

R. Goldsby, K. Janeway, R. Gorlick, 2018, Pediatric blood & cancer.

Rapid Protocol Enrollment in Osteosarcoma: A Report From the Children's Oncology Group

R. Goldsby, K. Janeway, R. Gorlick, 2016, Pediatric blood & cancer.

Clinical and Genetic Risk Prediction of Subsequent CNS Tumors in Survivors of Childhood Cancer: A Report From the COG ALTE03N1 Study.

M. Hudson, L. Robison, J. Neglia, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children’s Oncology Group

W. Woods, J. Neglia, Zhengjia Chen, 2015, Journal of immunotherapy.

Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group.

C. Rodríguez-Galindo, A. L. Frazier, J. Cullen, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Inhaled Granulocyte-Macrophage Colony Stimulating Factor for First Pulmonary Recurrence of Osteosarcoma: Effects on Disease-Free Survival and Immunomodulation. A Report From the Children's Oncology Group

E. Kleinerman, D. Hawkins, M. Bernstein, 2010, Clinical Cancer Research.

Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group.

R. Goldsby, R. Randall, M. Bernstein, 2013, European journal of cancer.

A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425.

C. S. Turner, L. Constine, S. Lipshultz, 2009, Blood.

Successful Coordination and Execution of Nontherapeutic Studies in a Cooperative Group Setting: Lessons Learned from Children's Oncology Group Studies

S. Bhatia, W. Landier, A. Carter, 2008, Cancer Epidemiology Biomarkers & Prevention.

Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.

M. Relling, M. Hudson, W. Leisenring, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CCG 1953: Acute Lymphoblastic Leukemia in Infants: Analysis of Prognostic Factors: A Report from the Children’s Oncology Group.

N. Heerema, W. Woods, H. Sather, 2005 .

Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial

A. Gajjar, A. Levy, M. Fouladi, 2021, Pediatric blood & cancer.

BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group.

S. Perkins, K. Kelly, M. Weiner, 2011, Blood.

APE chemotherapy for children with relapsed Hodgkin disease: A Pediatric Oncology Group trial

W. London, C. Schwartz, P. D. de Alarcon, 2006, Pediatric blood & cancer.

Physical Activity and Colon Cancer Risk among Women in the California Teachers Study

D. Stram, A. Ziogas, H. Anton-Culver, 2007, Cancer Epidemiology Biomarkers & Prevention.

Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children's Oncology Group.

C. Rodríguez-Galindo, A. L. Frazier, J. Cullen, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.

L. Constine, D. Friedman, R. Sposto, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surveillance after initial surgery for Stage I pediatric and adolescent boys with malignant testicular germ cell tumors: Report from the Children's Oncology Group.

J. Cullen, J. Ross, J. Amatruda, 2014, Journal of pediatric surgery.

Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval‐Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group

S. Ranganathan, J. D. Femino, R. Gorlick, 2016, Pediatric blood & cancer.

A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology Group.

S. Baruchel, P. Adamson, A. Pappo, 2012, European journal of cancer.

A Randomized Trial of Caspofungin vs Triazoles Prophylaxis for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplant.

S. Alexander, W. Steinbach, T. Zaoutis, 2020, Journal of the Pediatric Infectious Diseases Society.

Perspectives and attitudes on the use of adjuvant chemotherapy and trastuzumab in older adults with HER-2+ breast cancer: a survey of oncologists.

A. Naeim, S. Bhatia, S. Pal, 2009, The oncologist.

Assessment of extent of surgical resection of primary high‐grade osteosarcoma by treating institutions: A report from the Children's Oncology Group

R. Randall, M. Bernstein, L. Teot, 2016, Journal of surgical oncology.